In renal cancer, loss-of-function mutations of VHL can cause HIF1α stabilisation, thereby inducing VEGF and PDGF overexpression and sustained tumour angiogenesis (Le Tourneau et al, 2007). This evidence concerns the gene VEGFA and neoplasm.